STOCKHOLDERS' EQUITY

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

STOCKHOLDERS' EQUITY

NOTE 14—STOCKHOLDERS' EQUITY

Capital Stock

We participate in an “at-the-market” equity offering program (“ATM program”), pursuant to which we may, from time to time, sell up to $1.0 billion aggregate gross sales price of shares of our common stock. There were no issuances under the ATM program for the three months ended March 31, 2022. As of March 31, 2022, $1.0 billion aggregate gross sales price of shares of our common stock remains available for issuance under the ATM program.

Accumulated Other Comprehensive Loss

The following is a summary of our accumulated other comprehensive loss (dollars in thousands):

	As of March 31, 2022		As of December 31, 2021
Foreign currency translation loss	$	(66,784)	$	(56,227)
Unrealized gain on available for sale securities	1,249		1,836
Unrealized gain (loss) on derivative instruments	6,239		(10,129)
Total accumulated other comprehensive loss	$	(59,296)	$	(64,520)